| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $137 ...
Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $125 to $117.
JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $127 to $120.
Clorox (NYSE:CLX) affirms FY2026 Adj EPS guidance from $5.95-$6.30 to $5.95-$6.30 vs $5.95 analyst estimate..
Clorox (NYSE:CLX) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.79 by 8.01 per...
Wall Street opened the week on a mixed note on Monday.
Clorox (CLX) to release Q1 earnings on Nov. 3, analysts expect 78 cents/share, down from $1.86 last year. Annual dividend yield...